MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe
LA JOLLA, Calif., May 05, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Spark SEO Unveils Bold Rebrand and Strategic Shift to AI Search